A century of quiet revolution, a decade of urgent reform, and a roadmap to Viksit Bharat 2047 “Impact is not created by individuals in isolation—it is built by systems working in synchrony. Together, we move from data… to decision… to impact.” As the nation advances toward the vision of Viksit Bharat 2047, the question before us is not only how we treat disease, but how we build a health system that is anticipatory, equitable, and innovation-driven. At the heart of this transformation lies a reimagined approach to health research, one that connects data to decisions and decisions to impact.
Building on the hard-earned lessons of the COVID-19 pandemic, the Indian Council of Medical Research (ICMR), India’s apex body for biomedical research, has undertaken a series of forward-looking reforms. The reforms range from reimagining its institutional architecture to strengthening the way research is funded and translated into impact. What was once a system rooted in fragmented, investigator-led inquiry is now evolving into a technology-driven, mission-oriented ecosystem. This shift is not merely administrative, it is philosophical. It reflects a deliberate move toward integrated, institute-led research aligned with national priorities, where science is designed not just to generate knowledge, but to solve pressing public health challenges.
A cornerstone of this transformation is the restructuring of ICMR’s institutional architecture. Recent reforms have expanded the mandates of several institutes, repositioning them as interdisciplinary hubs rather than narrowly defined entities. The evolution of institutes toward domains such as digital health and data science, child health, women health, blood and immune disorders, reflects the changing contours of India’s disease burden and technological capabilities. Another important step is the creation of a network of regional National Institutes of Health Research across the country, from Dibrugarh in the Northeast to Jodhpur in the West. These institutes will conduct operational research closely with state and district health systems to ensure that relevant research is conducted and the output is used on the ground. These are not nominal changes, they signal a strategic reorientation toward future-ready science, where artificial intelligence, genomics, and real-time data systems are integral to public health decision-making.
Equally important is the shift from siloed functioning to a connected national research ecosystem. Institutes are now envisioned as resource centres that contribute to a shared national mission, ensuring that evidence generated in one setting informs action across the country. This systems-level thinking is critical in an era where health challenges, be it antimicrobial resistance, pandemics, or non-communicable diseases, are complex and interconnected. Parallel to institutional reforms is a fundamental redesign of the research funding ecosystem. The divide between intramural and extramural research is more transparent in terms of funding mechanism. But at the same time, they are bridged through a more cohesive and outcome-oriented framework. Intramural research is now largely institute-initiated, aligned with clearly defined mandates and structured within predictable timelines to accelerate translation. Extramural research, on the other hand, has been reorganized into a four-stage innovation cycle: Description, Discovery, Development, and Delivery, ensuring that promising ideas are systematically nurtured into scalable solutions.
This integrated continuum, from laboratory discovery to population-level delivery, marks a decisive shift from funding projects to enabling solutions. It is further reinforced by the National Health Research Programme (NHRP), which has identified thirteen priority areas ranging from antimicrobial resistance and tuberculosis to mental health, nutrition, and emergency care. These mission-mode programs are designed to foster multi-institutional collaboration, supported by substantial investments and a clear focus on measurable outcomes.
Technology, too, is playing a transformative role. The integration of artificial intelligence into diagnostics, surveillance, and program implementation is helping bridge longstanding gaps between urban and rural healthcare. AI-enabled tools for tuberculosis and diabetic retinopathy screening are already supporting frontline health workers, while innovations such as AI-driven nutritional monitoring are improving program delivery at scale. The i-Drone initiative, which began with vaccine delivery and has expanded to transport critical medical supplies such as corneas, exemplifies how cutting-edge technology can overcome geographic barriers and bring care closer to communities. At the frontier of science, advances across the medtech gamut, from medical devices and diagnostics to next-generation vaccines and therapeutics, are enabling more targeted, patient-centric interventions. In parallel, the integration of traditional knowledge systems through innovative, evidence-based models is gaining global recognition. These efforts are reinforced by a strong push toward indigenous innovation. Schemes like First in the World Challenge complemented with platforms such as MedTechMitra and the Medical Innovations–Patent Mitra initiative are accelerating the journey from research to commercialization, ensuring that publicly funded science translates into affordable, accessible technologies for the people.
The true measure of these reforms, however, lies in their impact on public health. Initiatives such as the India Hypertension Control Initiative have demonstrated how evidence-based strategies can transform chronic disease management at scale. Mission-mode programs in emergency care, including mobile stroke units and rapid cardiac response systems, are redefining outcomes in life-threatening conditions. Expanded diagnostic networks and indigenous technologies are strengthening early detection and treatment across diseases ranging from cancer to infectious outbreaks. These efforts are closely aligned with the National Health Policy 2017, which emphasizes preventive and promotive healthcare, universal access, and quality of care. They also reflect a broader commitment to equity ensuring that the benefits of scientific progress reach every citizen regardless of geography or socioeconomic status. As we look to the future, the vision is clear. ICMR will continue to serve as a catalyst, bringing together researchers, clinicians, policymakers, and industry to build a resilient and responsive health ecosystem. The roadmap to 2047 will be shaped by advances in digital health, bio-manufacturing, and sustainable development, with a strong emphasis on capacity building and global collaboration.
It is important to recognize that health research is not an isolated endeavor, it is a collective national enterprise. The transformation underway within ICMR is an invitation to all stakeholders to participate in this journey, to co-create solutions, and to ensure that science serves society in the most meaningful way. A reformed health research system is not an end in itself. It is the foundation upon which a healthier, more equitable, and more resilient India will be built, an India where every discovery leads to delivery, and every innovation translates into impact.
(The author is the Secretary, Department of Health Research, MoHFW and DG, Indian Council of Medical Research)
Dr. Rajiv Bahl